TOKYO, July 19, 2011 /PRNewswire/ -- Building on its cardiovascular portfolio, Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo), is proud to announce the launch of LIXIANA® (JAN: Edoxaban Tosilate Hydrate, INN: edoxaban) in Japan.

Tokyo, Nov. 30 (Jiji Press)--Major Japanese drug maker Daiichi Sankyo Co. said Friday it will sell two noncore firms to chemical maker Nippon Shokubai Co. for some 11 billion yen.

By Kyodo News International, Tokyo Sep. 29--TOKYO -- Mitsui Chemicals Inc. said Friday it will buy Daiichi Sankyo Co.'s pesticide manufacturing unit Sankyo Agro Co. with the aim of strengthening its agrichemical business.

By Kyodo News International, Tokyo Apr. 3--TOKYO -- Standard & Poor's said Monday its ratings on Daiichi Sankyo Co. and Astellas Pharma Inc. will be unaffected by Daiichi Sankyo's acquisition of Astellas' over-the-counter drug subsidiary, Zepharma Inc., later in April.

Tokyo, March 31 (Jiji Press)--Major drug maker Daiichi Sankyo Co. said Friday that no decision has been made on whether to buy Zepharma Inc., a fully owned Astellas Pharma Inc. unit that makes over-the-counter drugs.